Trailing-twelve-month (TTM) revenue is $3.92 Billion with a year-over-year growth of +9.90%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,026,106,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $912,913,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-12 |
| Q1 FY2026Period ended 2026-03-31 | $906,424,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-23 |
| Q2 FY2026Period ended 2026-06-30 | $1,078,576,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-23 |
| TTM revenue | $3,924,019,000 |
Current P/S: $15,632,414,176 market capitalization ÷ $3,924,019,000 TTM revenue = 3.98x.
Market capitalization source: FMP quote. Quote observed 2026-09-23T20:00:02.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.08B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-24T00:16:25.434Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Commercial Contract Revenue | $767M | N/A | N/A | N/A | $1.1B | $1.2B |
| Commercial revenue | N/A | $845M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20182018-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Non-US | $144M | $184M | $197M | $220M | $245M | $270M |
| UNITED STATES | $1.7B | $2.2B | $2.5B | $2.9B |
$3.92B
$3.92 Billion
+9.90%
vs. $3.57B a year ago (TTM)
+11.34%
5 Year compound annual growth rate
1 Year
+9.90%
3 Year
+10.99%
5 Year
+11.34%
10 Year
+9.91%
15 Year
+8.36%
20 Year
+8.07%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $3.76B | +$372.34M | +10.99% |
| 2024 | $3.39B | +$315.43M | +10.26% |
| 2023 | $3.07B | +$377.45M | +14.00% |
| 2022 | $2.70B | +$271.52M | +11.20% |
| 2021 | $2.42B | +$263.08M | +12.17% |
| 2020 |
TTM Growth
+9.90%
3-Year CAGR
+10.99%
5-Year CAGR
+11.34%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-24T00:16:25.434Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| N/A |
| Commercial Revenue | N/A | N/A | N/A | $1.0B | N/A | N/A |
|---|
| Franchise | N/A | N/A | N/A | $17M | N/A | N/A |
|---|
| Franchise revenues | N/A | N/A | $16M | N/A | N/A | N/A |
|---|
| Franchise Revenues | N/A | N/A | N/A | N/A | $17M | $16M |
|---|
| Other revenues | N/A | $11M | $16M | N/A | N/A | N/A |
|---|
| Other Revenues | $10M | N/A | N/A | $17M | $23M | $25M |
|---|
| Residential Contract Revenue | $977M | N/A | N/A | N/A | $1.5B | $1.7B |
|---|
| Residential revenue | N/A | $1.1B | $1.2B | N/A | N/A | N/A |
|---|
| Residential Revenue | N/A | N/A | N/A | $1.4B | N/A | N/A |
|---|
| Termite completions, bait monitoring, & renewals | N/A | $465M | $537M | N/A | N/A | N/A |
|---|
| Termite Completions, Bait Monitoring, & Renewals | N/A | N/A | N/A | N/A | $688M | N/A |
|---|
| $3.5B |
| $2.16B |
| +$145.74M |
| +7.23% |
| 2019 | $2.02B | +$193.91M | +10.65% |
| 2018 | $1.82B | +$147.61M | +8.82% |
| 2017 | $1.67B | +$100.48M | +6.39% |
| 2016 | $1.57B | +$88.17M | +5.94% |
